These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 6238917)
1. Antimicrobial properties of gentamicin on the skin. Lorenzetti OJ; Wernet TC; Breslauer CM Int J Dermatol; 1984 Oct; 23(8):547-9. PubMed ID: 6238917 [No Abstract] [Full Text] [Related]
2. Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones. Resh W; Stoughton RB Arch Dermatol; 1976 Feb; 112(2):182-4. PubMed ID: 134675 [TBL] [Abstract][Full Text] [Related]
3. In vitro Antimicrobial Activity of Acne Drugs Against Skin-Associated Bacteria. Blaskovich MAT; Elliott AG; Kavanagh AM; Ramu S; Cooper MA Sci Rep; 2019 Oct; 9(1):14658. PubMed ID: 31601845 [TBL] [Abstract][Full Text] [Related]
4. Topical acne treatments in Europe and the issue of antimicrobial resistance. Leccia MT; Auffret N; Poli F; Claudel JP; Corvec S; Dreno B J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1485-92. PubMed ID: 25677763 [TBL] [Abstract][Full Text] [Related]
5. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents. Nishijima S; Kurokawa I; Kawabata S J Int Med Res; 1996; 24(6):473-7. PubMed ID: 8959531 [TBL] [Abstract][Full Text] [Related]
6. Spread of antibiotic-resistant bacteria from acne patients to personal contacts--a problem beyond the skin? Bolognia JL; Edelson RL Lancet; 1997 Oct; 350(9083):972-3. PubMed ID: 9329508 [No Abstract] [Full Text] [Related]
7. A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria. Owen L; Grootveld M; Arroo R; Ruiz-Rodado V; Price P; Laird K Phytother Res; 2017 Mar; 31(3):410-417. PubMed ID: 28124400 [TBL] [Abstract][Full Text] [Related]
11. Direct analysis of resistance in the cutaneous microflora during treatment of acne vulgaris with topical 1% nadifloxacin and 2% erythromycin. Bojar RA; Hittel N; Cunliffe WJ; Holland KT Drugs; 1995; 49 Suppl 2():164-7. PubMed ID: 8549289 [No Abstract] [Full Text] [Related]
14. Antibiotic resistance of Propionibacterium acnes in acne vulgaris. Swanson JK Dermatol Nurs; 2003 Aug; 15(4):359-62. PubMed ID: 14515616 [TBL] [Abstract][Full Text] [Related]
15. Propionibacterium acnes and antimicrobial resistance in acne. Dessinioti C; Katsambas A Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353 [TBL] [Abstract][Full Text] [Related]
16. Antibiotic resistance in the topical treatment of acne vulgaris. Leyden JJ Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128 [TBL] [Abstract][Full Text] [Related]
17. Propionibacterium acnes resistance to antibiotics in acne patients. Leyden JJ; McGinley KJ; Cavalieri S; Webster GF; Mills OH; Kligman AM J Am Acad Dermatol; 1983 Jan; 8(1):41-5. PubMed ID: 6219134 [TBL] [Abstract][Full Text] [Related]
18. An overview of topical antibiotics for acne treatment. Toyoda M; Morohashi M Dermatology; 1998; 196(1):130-4. PubMed ID: 9557247 [TBL] [Abstract][Full Text] [Related]
19. Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribers. Eady AE; Cove JH; Layton AM Am J Clin Dermatol; 2003; 4(12):813-31. PubMed ID: 14640775 [TBL] [Abstract][Full Text] [Related]
20. Epidemiological survey of resistance to gentamicin and other reserve aminoglycosides in hospital bacteria. Rusu V; Dorobăţ O; Paicu L; Niţu R Arch Roum Pathol Exp Microbiol; 1982; 41(4):295-302. PubMed ID: 7171302 [No Abstract] [Full Text] [Related] [Next] [New Search]